Literature DB >> 3089662

A neonatal mouse model of meningococcal disease.

I E Salit, L Tomalty.   

Abstract

Neisseria meningitidis, the meningococcus, remains a major cause of bacterial meningitis. Previously developed animal models for this infection do not adequately mimic its natural pathogenesis in humans. We have investigated a number of different potential animal models and describe a neonatal mouse model. Meningococci were instilled intranasally into five-day-old mice; invasiveness was measured by blood cultures and cisternal puncture, and colonization was determined by nasal cultures. Fifty two percent of mice became bacteremic after instillation of strains which are virulent for humans. Human carrier strains were avirulent in this model. Iron dextran enhanced the nasal colonization, invasiveness and mortality due to disease-associated isolates but had no effect on carrier strains. Colonization rates were similar for all strains. There was a marked age-related change in susceptibility to infection which was inversely correlated with levels of serums C3. Immunization of Swiss CD1 dams with N. meningitidis serotype 2 vaccine protected their litters from meningococcal infection. Protective levels of serum antibody were acquired by neonatal mice after suckling immunized dams. The neonatal mouse meets most of the criteria for an appropriate animal model for meningococcemia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089662

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  5 in total

1.  Assessment of the nasopharyngeal bacterial flora of rhesus macaques: moraxella, Neisseria, haemophilus, and other genera.

Authors:  Lisa C Bowers; Jeanette E Purcell; Gail B Plauché; Philippe A Denoel; Yves Lobet; Mario T Philipp
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Growth of Neisseria gonorrhoeae in the female mouse genital tract does not require the gonococcal transferrin or hemoglobin receptors and may be enhanced by commensal lactobacilli.

Authors:  Ann E Jerse; Emily T Crow; Amy N Bordner; Ishrat Rahman; Cynthia Nau Cornelissen; Thomas R Moench; Karim Mehrazar
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

3.  Development and evaluation of an improved mouse model of meningococcal colonization.

Authors:  Kyungcheol Yi; David S Stephens; Igor Stojiljkovic
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

4.  The meningococcal ABC-Type L-glutamate transporter GltT is necessary for the development of experimental meningitis in mice.

Authors:  Roberta Colicchio; Susanna Ricci; Florentia Lamberti; Caterina Pagliarulo; Chiara Pagliuca; Velia Braione; Tiziana Braccini; Adelfia Talà; Donatella Montanaro; Sergio Tripodi; Marcella Cintorino; Giancarlo Troncone; Cecilia Bucci; Gianni Pozzi; Carmelo B Bruni; Pietro Alifano; Paola Salvatore
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

5.  Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis.

Authors:  Susanna Ricci; Denis Grandgirard; Michael Wenzel; Tiziana Braccini; Paola Salvatore; Marco R Oggioni; Stephen L Leib; Uwe Koedel
Journal:  BMC Infect Dis       Date:  2014-12-31       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.